成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Struktur
1809002-40-1
CAS-Nr.
1809002-40-1
Englisch Name:
1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Synonyma:
Tofacitinib Impurity N (Citrate);Tofacitinib Related Compound 21 Citrate;1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
CBNumber:
CB54920840
Summenformel:
C22H30N6O8
Molgewicht:
506.52
MOL-Datei:
1809002-40-1.mol

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Eigenschaften

Sicherheit

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422
 sale@hdimpurity.com China 3389 58
Guangzhou CATO Research Chemicals Inc. 		+86-020-81960175-617 +8615602392859
 Intermediate@cato-chem.com China 8322 58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD 0755-0755-0755-83725350 13380397412
 3001280422@qq.com China 10005 58
Molcoo Chemicals Inc. 18576690171 17386083646
 3001006472@qq.com China 11837 58
PureChemland Co.,Ltd. 028-64441822 18581895003
 3848291069@qq.com China 3337 58
Guangzhou Langou Biotech Co., Ltd. 15876533741
 2201851245@qq.com China 468 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 18126517264
 2850476883@qq.com China 7858 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627756402
 3001009495@qq.com China 19063 58
Cato Research Chemicals Inc. 13342851930
 3008394369@qq.com China 15726 58
  • 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • Tofacitinib Impurity N (Citrate)
  • 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • Tofacitinib Related Compound 21 Citrate
  • 1809002-40-1
Copyright 2019 ? ChemicalBook. All rights reserved